Literature DB >> 19235928

Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.

Flavio Nobili1, Giovanni Abbruzzese, Silvia Morbelli, Roberta Marchese, Nicola Girtler, Barbara Dessi, Andrea Brugnolo, Cinzia Canepa, Giorgos Chr Drosos, Gianmario Sambuceti, Guido Rodriguez.   

Abstract

The purpose of this study was to investigate cortical dysfunction in Parkinson's disease (PD) patients with amnestic deficit (PD-MCI). Perfusion single photon emission computed tomography was performed in 15 PD-MCI patients and compared (statistical parametric mapping [SPM2]) with three groups, i.e., healthy subjects (CTR), cognitively intact PD patients (PD), and common amnestic MCI patients (aMCI). Age, depression, and UPDRS-III scores were considered as confounding variables. PD-MCI group (P < 0.05, false discovery rate-corrected for multiple comparisons) showed relative hypoperfusion in bilateral posterior parietal lobe and in right occipital lobe in comparison to CTR. As compared to aMCI, MCI-PD demonstrated hypoperfusion in bilateral posterior parietal and occipital areas, mainly right cuneus and angular gyrus, and left precuneus and middle occipital gyrus. With a less conservative threshold (uncorrected P < 0.01), MCI-PD showed hypoperfusion in a left parietal region, mainly including precuneus and inferior parietal lobule, and in a right temporal-parietal-occipital region, including middle occipital and superior temporal gyri, and cuneus-precuneus, as compared to PD. aMCI versus PD-MCI showed hypoperfusion in bilateral medial temporal lobe, anterior cingulate, and left orbitofrontal cortex. PD-MCI patients with amnestic deficit showed cortical dysfunction in bilateral posterior parietal and occipital lobes, a pattern that can be especially recognized versus both controls and common aMCI patients, and to a lesser extent versus cognitively intact PD. The relevance of this pattern in predicting dementia should be evaluated in longitudinal studies. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2009        PMID: 19235928     DOI: 10.1002/mds.22381

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  23 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

2.  Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease.

Authors:  Kurt Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2011-09-30       Impact factor: 3.575

Review 3.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

4.  Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Jennifer G Goldman; Holly Weis; Glenn Stebbins; Bryan Bernard; Christopher G Goetz
Journal:  Mov Disord       Date:  2012-07-06       Impact factor: 10.338

Review 5.  Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Authors:  Jennifer G Goldman; Neelum T Aggarwal; Cynthia D Schroeder
Journal:  Neurodegener Dis Manag       Date:  2015-10-30

6.  Gray matter atrophy in patients with Parkinson's disease and those with mild cognitive impairment: a voxel-based morphometry study.

Authors:  Jing Zhang; Yun-Ting Zhang; Wei-Dong Hu; Li Li; Guang-Yao Liu; Yu-Ping Bai
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; John F Pearson; Sina Rüeger; Toni L Pitcher; Leslie Livingston; Charlotte Graham; Ross Keenan; Ajit Shankaranarayanan; David C Alsop; John C Dalrymple-Alford; Tim J Anderson
Journal:  Brain       Date:  2011-02-09       Impact factor: 13.501

8.  Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.

Authors:  G Stennis Watson; Brenna A Cholerton; Rachel G Gross; Daniel Weintraub; Cyrus P Zabetian; John Q Trojanowski; Thomas J Montine; Andrew Siderowf; James B Leverenz
Journal:  Alzheimers Dement       Date:  2012-11-16       Impact factor: 21.566

9.  Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease.

Authors:  Flavio Nobili; Dario Arnaldi; Claudio Campus; Michela Ferrara; Fabrizio De Carli; Andrea Brugnolo; Barbara Dessi; Nicola Girtler; Silvia Morbelli; Giovanni Abruzzese; Gianmario Sambuceti; Guido Rodriguez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-09       Impact factor: 9.236

10.  [Voxel-based analysis of cerebral blood flow changes in Parkinson disease using arterial spin labeling technique].

Authors:  Rong Zhao; Tianzhong Wang; Zhengli Di; Junle Yang; Min Xu; Zhiqin Liu; Xurong Zhu; Xiaoping Wu; Xiaoyu Gao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.